Table 3 Incidence rates and risks of AVF/AVG dysfunction in SLE and non-SLE patients.
Vascular access type | SLE patients | Non-SLE patients (reference) | Crude | Competing risk | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
No. of Events | Person-years | Incidence ratea | No. of Events | Person-years | Incidence ratea | HR (95% CI) | P | SHR (95% CI) | P | |
AVF | 780 | 33,724.2 | 20.94 | 2173 | 11,393.9 | 19.07 | 1.09 (1.00, 1.18) | 0.045 | 1.10 (1.01–1.19) | 0.022 |
AVG | 144 | 202.7 | 71.06 | 416 | 556.3 | 74.78 | 0.94 (0.78, 1.14) | 0.540 | 1.00 (0.83–1.20) | 0.992 |